Bio-Path Holdings, Inc.
BPTH· OTC
Filed May 14, 2024 · 10-Q · 44 days after period end · 0001558370-24-008135
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Net Income | -$3.16M | -$5.27M | -$3.36M | -$2.45M |
| EPS Diluted | -$4.88 | -$13.25 | -$0.47 | -$0.43 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Path Holdings, Inc. · CIK 1133818 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 14, 2024 · 44 d after period end